Ellipsis Health, The company using AI Voice Agent Technology has announced that it has raised $45 million in the new Series A funding round.
SalesforceKhosla Ventures and CVS Health Ventures led the round. Mitsui Global Investment, Collier, E12 and Ame Cloud Ventures took part in the round.
The company also introduces Sage, an AI care manager that aims to help patients in the body. Behavioral and social needs.
What it does
Ellipsis Health Use vocal biomarkers to identify mental disorders such as anxiety and depression.
According to the company, Sage aims to “expand provider capabilities, streamline workflows, and increase patient engagement.”
Sage leverages Ellipsis’ empathy engine based on its patented vocal biomarker technology and is trained with millions of live clinical patient calls.
In a statement, Ellipsis said that Sage is “emotionally intelligent and adjusts its tone and approach based on the patient’s emotional state and mental health needs, ensuring a high level of engagement and behavioral change.”
The company will use its funds to speed up sage recruitment across healthcare providers, payers and care management organizations. The company is also considering expanding its AI capabilities and enhancing clinical integration.
“Sage will derive clinical understanding from our experience developing vocal biomarkers in case management conversations and build an empathic and longitudinal care journey by leveraging Salesforce’s Health Cloud with our clinical partners.
Bigger trends
Ellipsis Health rose in 2021 Series A funding amounted to $26 million. Ellipsis said capital will be used to add more customers, expand global partnerships, build teams and explore new voice-based technologies.
That same year, Cigna International launched a A digital tool that evaluates a person’s stress level. The company partnered with Ellipsis Health to develop the Cigna Stresswaves test. It is touted as the world’s first voice activation stress test.
Cigna said the technology has been researched and developed for 20 years. The AI ​​tool algorithm developed by Ellipsis Health was trained on a data set containing over 15,000 adults aged 18 and older, allowing it to accommodate a diverse population with a variety of accents and English proficiency.
Other companies in the AI ​​Voice Technology space include DoctorPresso, which developed the mental health diary app in 2024, used the generated AI to screen for depression early, while ensuring confidential user data.
A mobile app called Redi analyzes user speech patterns and provides near-real-time insights into mental states.
Through AI, the app analyzes four audio characteristics: average pitch, pitch variability, spectral center of gravity, and spectral roll-off.
These factors, reportedly changing as depression worsens, are used to classify whether users are not depressed, have mild depression, or have experienced a major episode of depression.
